Valvular heart disease associated with fenfluramine-phentermine
Redmon, B.; Raatz, S.; Bantle, J.P.
New England Journal of Medicine 337(24): 1773-1774; Author Reply 1775
1997
ISSN/ISBN: 0028-4793 PMID: 9411249 Document Number: 476631
Document emailed within 1 workday
Related Documents
Spitzer, W.O. 1997: Valvular heart disease associated with fenfluramine-phentermine New England Journal of Medicine 337(24): 1774-1775; Author Reply 1775-1776Lichodziejewska, B. 1993: Management of patients with valvular heart disease and poor ventricular function. the Working Group on Valvular Heart Disease Kardiologia Polska 39(10): 316-317
Gohlke-Bärwolf, C.; Acar, J.; Oakley, C.; Butchart, E.; Burckhart, D.; Bodnar, E.; Hall, R.; Delahaye, J.P.; Horstkotte, D.; Krémer, R. 1995: Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology European Heart Journal 16(10): 1320-1330
Rothman, R.B. 1996: Smoking cessation in a patient being treated with fenfluramine plus phentermine for simple obesity Journal of Clinical Psychiatry 57(2): 92-93
Rosa, V.E.E.; Lopes, A.S.S.A.; Accorsi, T.A.D.; Fernandes, J.R.C.; Spina, G.S.; Sampaio, R.O.; Bacal, F.; Tarasoutchi, F. 2015: Heart Transplant in Patients with Predominantly Rheumatic Valvular Heart Disease Journal of Heart Valve Disease 24(5): 629-634
Sukhum, P.; McBride, J.W.; Long, L.A.; Campion, B.C. 1980: Echocardiography of valvular heart disease: evaluation of heart murmurs Minnesota Medicine 63(12): 869-877
Savova, A.; Stoitchev, S.; Ovanesyan, H.; Finkov, B.; Belov, J. 1986: Coronary artery disease in patients with valvular heart disease Zeitschrift für Kardiologie 75(Suppl 2): 73-75
Rasmussen, V.G.; Dupont, E.; Østergaard, K.; Egeblad, H. 2006: Valvular heart disease associated with the treatment of Parkinson disease Ugeskrift for Laeger 168(26-32): 2542-2544
Michel, P.L.; Garbarz, E.; Messika-Zeitoun, D.; Roussin, I. 2000: The best of valvular heart disease in 1999 Archives des Maladies du Coeur et des Vaisseaux 93(1 Spec No): 97-102
Domenech, B.; Pomar, J.é L.; Prat-González, S.; Vidal, B.ár.; López-Soto, A.; Castella, M.; Sitges, M. 2016: Valvular Heart Disease Epidemics Journal of Heart Valve Disease 25(1): 1-7
Calleja, H.B.; Moreno, F.L.; Yulde, J.A.; Orozco-Regalado, M.C.; Palileo, M.R. 1980: Two dimensional echocardiography in valvular heart disease Annals of the Academy of Medicine Singapore 9(4): 421-429
Livi, U.; Caforio, A.L.; Grassi, G.; Boffa, G.M.; Barchitta, A.; Gambino, A.; Thiene, G.; Casarotto, D. 1995: Heart transplantation for end-stage valvular disease Transplantation Proceedings 27(1): 1305-1306
Kumar, A.S. 1999: Valvular heart disease--repair or replacement? Journal of the Indian Medical Association 97(7): 282-286
Aragona, P.; Galati, A.; Savino, K.; Pino, G.P.; Terranova, A. 2007: Stress echocardiography in valvular heart disease Giornale Italiano di Cardiologia 8(12): 735-748
Yasumura, Y. 2004: Natriuretic peptides and valvular heart disease Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 9): 93-94
Gray, R.J.; Helfant, R.H. 1993: Timing of surgery for valvular heart disease Cardiovascular Clinics 23: 209-231
Fontana, M.E.; Lewis, R.P. 1985: Evaluation of valvular heart disease by invasive methods Cardiovascular Clinics 15(1): 165-185
Thompson, P.D. 1999: Evaluating and managing athletes with valvular heart disease Connecticut Medicine 63(11): 665-675
Gohlke-Bärwolf, C.; Krémer, R. 1996: Prevention of thromboembolic events in valvular heart disease Acta Cardiologica 51(2): 129-142
Iskandrian, A.S.; Hakki, A.H. 1986: Scintigraphic evaluation of patients with valvular heart disease Cardiovascular Clinics 16(2): 211-230